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Abstract Biodistribution of nanoparticle-based intracel-
lular delivery systems is mediated primarily by particle size
and physicochemical properties. As such, overcoming the
rapid removal of these by the reticuloendothelial system
remains a significant challenge. To date, a number of
copolymer nanoparticle systems based on 2-methacryloy-
loxyethyl phosphorylcholine (MPC) with 2-(diisopropy-
lamino)ethyl methacrylate (DPA), displaying biomimetic
and pH responsive properties, have been published, how-
ever these have been predominately polymersome based,
whilst micelle systems have remained relatively unex-
plored. This study utilised nanoprecipitation to investigate
the effects of solvent and buffer choice upon micelle size
and polydispersity, and found using methanol produced
monodisperse micelles of circa 70 nm diameter, whilst
ethanol produced polydisperse systems with nanoparticles
of circa 128 nm diameter. The choice of aqueous buffer,
dialysis of the systems, extended storage, and exposure to a
wide temperature range (5–70 C) had no significant effect
on micelle size, and the systems were highly resistant to
dilution, indicating excellent colloidal stability. Optimisa-
tion of the nanoprecipitation process, post precipitation,
was investigated, and model drugs successfully loaded
whilst maintaining system stability. Subsequent in vitro
studies suggested that the micelles were of negligible
cellular toxicity, and an apparent cellular uptake was ob-
served via confocal laser scanning microscopy. This paper
presents the first report of an optimised nanoprecipitation
methodology for the formation of MPC–DPA nanoparticle
micelles, and in doing so achieved monodisperse systems
with the size and physicochemical characteristics seen as
desirable for long circulating therapeutic delivery vehicles.
1 Introduction
The research and development of systemically adminis-
trable nanoparticulate-based intracellular delivery systems
(NIDS) is driven by the need to overcome a number of key
challenges. The hurdles faced by NIDS include dilution
induced micelle dissociation, resulting in dose dumping,
and the more problematic rapid removal from the circula-
tory blood stream by the reticuloendothelial system (RES),
mediated by particle size and physichochemical properties
[1]. Whilst polymeric micelle systems have been shown to
be able to withstand dilution to low concentrations, and
thus offer the potential for systemic stability [2, 3], over-
coming the RES remains a challenge. The main organs of
the RES, the liver, spleen, and bone marrow, facilitate the
removal of conventional NIDS within minutes of intra-
venous injection [4].
Two major factors are involved in this rapid removal,
(i) opsonisation of the particle, and (ii) particle size. Op-
sonisation of NIDS occurs rapidly after injection [5] re-
sulting in a surface layer of proteins on the NIDS which
promote recognition and phagocytosis by the macrophages
of the RES. Particle size of the NIDS can modulate both
mechanical filtration and RES-based macrophage removal.
Micron size range particles face capillary filtration in the
lungs and spleen [6, 7], with particles of 1–2 lm having
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been shown to induce maximum phagocytosis [8]. There-
fore a sub-micron particle size is considered desirable for a
long circulating NIDS. However particles above 200 nm
are subject to mechanical filtration by the spleen [9], whilst
those below 50 nm may be lost through the fenestrae that
occur throughout the capillary network of the liver, spleen,
and bone marrow [10, 11]. Thus the range of particle sizes
from 50 to 200 nm in diameter appears to offer the pro-
spect of resistance to RES clearance. However, it has also
been suggested that the use of protective surface coating
technologies to extend nanoparticle circulatory times is less
effective for particles with diameters greater than 150 nm
[9], are more effective for particles within a narrower 60 to
100 nm size range [12]. When a NIDS possesses long
circulating properties, tumour targeting can be achieved via
the enhanced permeation and retention (EPR) effect, which
will result in the passive accumulation of the NIDS at the
tumour site via the leaky vasculature [13]. The long cir-
culating properties are desirable as it has been hypothesised
that a minimum of six hours are required for there to be
effective EPR accumulation [14].
A number of successful biomedical materials have been
successfully developed utilising phosphorylcholine (PC)
[15] which possess biomimetic biocompatibility achieved
by mimicking the surface of natural phospholipid mem-
brane bilayers [16]. This could, in principle, reduce the
protein adsorption and cell activation of NIDS containing
PC, and therefore avoid macrophage-mediated RES
removal.
Since the early reports of PC containing MPC–DPA
nanoparticle systems [17, 18], there has been significant
progress on the development of these in the form of
polymeric vesicles, akin to liposomes, known as poly-
mersomes [19, 20], whereas research into their further
development as micelle-based NIDS has been more limit-
ed. Nevertheless, progress has been made with regard to
demonstrating the continued potential for MPC–DPA
based micelles to be effective NIDS [21, 22]. As such, this
paper reports on the development of MPC100–DPA100
based micelle systems, which we have previously demon-
strated possess some of the key attributes desirable in a
NIDS: including drug analogue loading and release, pH
responsiveness, dilution stability, and low cellular toxicity;
but which were found to be below 50 nm in diameter, and
of a polydisperse nature, having been formed by via a pH
titration method [17]. Herein this paper reports the novel
development and optimisation of a rapid and straightfor-
ward nanoprecipitation based method to achieve repro-
ducible production of monodisperse MPC–DPA micelles.
In doing so, this study investigated the effects of solvent
and buffer choice, hydrophobic model drug loading, system
temperature, and polymer concentration on the particle
dynamics of the polymeric micelles formed, and is to the
best of our knowledge the first report of this MPC100–
DPA100 nanoprecipitated micelle system.
2 Materials and methods
2.1 MPC100–DPA100 diblock copolymer
The 100–100 diblock length copolymer, comprised of
2-methacryloyloxyethyl phosphorylcholine (MPC) with
2-(diisopropylamino)ethyl methacrylate (DPA), was sup-
plied by Prof Steven Armes (University of Sheffield, UK),
having been synthesised via atom transfer radical
polymerisation (ATRP), and characterised with nuclear
magnetic resonance (NMR) and gel permeation chro-
matography (GPC), as detailed previously [17, 18], where
1H NMR and GPC indicated the block copolymer was well
defined with Mn and polydispersity values of 51,000 and
1.27 respectively.
2.2 Preparation of polymeric micelle systems
via nanoprecipitation
2.2.1 Solvent ratio, time, and dialysis effect
Solutions of the MPC100–DPA100 copolymer (40 mg ml
-1)
were prepared in methanol (MeOH) (Fisher, UK) and
ethanol (EtOH) (Fisher, UK), and MeOH:EtOH volume
combination ratios of 3:1, 1:1, and 1:3. Aliquots (100 ll) of
these were added drop-wise, using a micropipette, to
9.9 ml of phosphate buffer saline (PBS) (Oxoid, UK), pH
7.4, stirring with a 1 cm magnetic flea (1,250 rpm, 2 min)
and subsequently bath sonicated for 5 min. Final copoly-
mer concentration was 0.4 mg ml-1. The systems were
examined at time zero (t = 0) and at 6 weeks post micelle
formation (t = 6), (room temperature storage), and also pre
and post 1 week of dialysis, (8 kDa molecular weight cut-
off) (BioDesign, USA), in PBS (pH 7.4) with daily PBS
changes, using photon correlation spectroscopy (PCS).
2.2.2 Solvent, buffer, hydrophobic loading, dilution,
and temperature effect
Solutions of the MPC100–DPA100 copolymer (40 mg ml
-1)
were prepared in MeOH and EtOH with and without a
model hydrophobic compound Orange OT dye (OOT)
(Sigma, UK), at a polymer to OOT mol ratio of 2:1. Ali-
quots (100 ll) of these were added drop-wise to 9.9 ml of
PBS, pH 7.4, or MCIlvaines buffer (McB) (in-house), pH
7.4, stirring with a 1 cm magnetic flea (1,250 rpm, 2 min)
and subsequently bath sonicated for 5 min. The systems
were examined for dilution and temperature stability using
PCS.
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2.2.3 Stirring, sonication, and filtration effect
Solutions of the MPC100–DPA100 copolymer (40 mg ml
-1)
were prepared in MeOH, and aliquots (100 ll) of these
were added drop-wise to 9.9 ml of PBS, pH 7.4, under the
following preparation conditions: (A) no stirring, no
sonication, no filtration, (B) no stirring, no sonication,
0.22 lm pore size syringe filtered (Millipore), (C) stirring
(1,250 rpm, 2 min), sonication (5 min), no filtration,
(D) stirring (1,250 rpm, 2 min), sonication (5 min),
0.22 lm pore size syringe filtered.
2.2.4 Loading ratio of fluorescent probe
Solutions of the MPC100–DPA100 copolymer (40 mg ml
-1)
were prepared in MeOH with the fluorescent probe Nile
Red (NR) (Sigma, UK) at polymer to NR weight ratios of:
(A) 10:0.1, (B) 10:0.5, (C) 10:0.75, (D) 10:1. Aliquots
(100 ll) of these were added drop-wise to 9.9 ml of PBS,
pH 7.4, with no stirring or sonication, and the resultant
samples 0.22 lm pore size syringe filtered.
2.3 Particle size characterisation
Particle size characterisation of the prepared micelle sys-
tems was undertaken using photon correlation spectroscopy
(PCS), atomic force microscopy (AFM), and transmission
electron microscopy (TEM).
2.3.1 Photon correlation spectroscopy
The PCS instrument employed in this study was a Malvern
Zetasizer 3000HS, equipped with a 10 mW He–Ne laser
operating at a wavelength of 633 nm, together with a high
sensitivity avalanche photodiode detector (APD) at 90
collection angle. Sample temperature was maintained dur-
ing PCS measurement by a Peltier thermal cuvette mounting
stage. Each PCS size measurement had a duration of 600 s,
consisting of 30 analyses by the Malvern PCS software, of
fluctuations in the scattered light data collected by the APD,
in order to determine the intensity based hydrodynamic di-
ameter (Dh) and system polydispersity (Pd). The Dh being
calculated by the Stokes–Einstein equation (Dh = kT/
3pgd), where Dh = hydrodynamic diameter, d = diffusion
coefficient, k = Boltzmann’s constant, T = absolute tem-
perature, and g = viscosity.
The solvent ratio, time, and dialysis effect systems
(Sect. 2.2.1) were examined using PCS, at 25 C, to de-
termine the Dh and system Pd at time zero (t = 0) and at
6 weeks post micelle formation (t = 6), and also pre and
post 1 week of dialysis (8 kDa cut-off) in PBS (pH 7.4)
following daily PBS changes. Samples were filtered with
0.2 lm pore size syringe filters immediately prior to
measurement to ensure sample quality.
The solvent, buffer, hydrophobic compound loading,
dilution, and temperature effects on the systems
(Sect. 2.2.2) were examined using PCS, at 25 C, to de-
termine Dh and system Pd in response to solvent and buffer
variation, with and without OOT loaded in the systems.
The dilution stability of the PBS systems was examined at
25 C, by measuring signal intensity (KCps), Dh and Pd in
response to halving dilutions of the micelle solutions made
using pre-filtered (0.2 lm) PBS (pH 7.4). The diluted
samples were filtered with 0.2 lm pore size syringe filters
immediately prior to measurement, as before. The thermal
stability of the PBS systems was examined by measuring
the Dh and Pd across the temperatures range of 5–70 C, at
5 C intervals. Samples were equilibrated for 20 min after
each 5 C temperature change before PCS measurement
commenced, to ensure only Brownian motion was mea-
sured. The stirring, sonication and filtration effects on the
systems (Sect. 2.2.3) were examined using PCS, at 25 C,
to determine Dh and system Pd, without further sample
filtration.
The effects of loading ratio of a fluorescent probe
(Sect. 2.2.4) were examined using PCS, at 25 C, to de-
termine Dh and system Pd. Samples were filtered through a
0.2 lm pore size syringe filter immediately prior to mea-
surement. Post instrument loading, the samples were al-
lowed to equilibrate for 1 min per degree of temperature
change, plus 5 min, from the room temperature before PCS
measurement commenced at 25 C.
2.3.2 Atomic force microscopy
MPC100–DPA100 dissolved in MeOH (40 mg ml
-1) was
added drop wise to pH adjusted deionised water (D.I.)
under the same conditions used to prepare the PBS based
system in Sect. 2.2.2. The micelle solution was then ap-
plied drop-wise to a mica wafer (in house) and air dried.
The AFM imaging was carried out using a VEECO
Nanoscope 111A atomic force microscope in Tapping
ModeTM, operating at a scan rate of 0.5 Hz, a scan size of
3 lm, and using Point probes type PPP-NCH-W tips
(Nanosensors).
2.3.3 Transmission electron microscopy
The MPC100–DPA100 micelle solution, as described in
Sect. 2.3.2, was mixed with 2 % phosphotungstic acid (pH
7.4) (Sigma, UK) at a 1:1 volume ratio as a negative stain,
and then applied drop-wise to Formvar coated copper grids
(Agar Scientific) and allowed to air dry. The prepared grids
were imaged using a Phillips CM10 TEM at an accelerat-
ing voltage of 80 kV. Deionised water (pH adjusted) was
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employed for the AFM and TEM samples to minimise
presence of salts upon drying.
2.4 Cell study
2.4.1 In-vitro cell cytotoxicity study
The cytotoxicity assay used was based on published
methods [23], and had been previously employed to suc-
cessfully test MPC–DPA micelle systems [17]. MPC100–
DPA100 (MeOH–PBS) (pH 7.4) based micelle systems
were prepared at 0.4 mg ml-1, as per Sect. 2.2.2. Hamster
lung V79 fibroblast cells (Japanese Cancer Research Re-
sources Bank (JCRB), Japan) were maintained in Dulbec-
co’s Modified Essential Medium (DMEM) (PAA, UK)
supplemented with 10 % foetal calf serum (FCS) (PAA,
UK) and 1 % penicillin and streptomycin (P&S) (PAA
Labs). 24 well plates (Nunc, UK) were seeded with 100
V79 cells per well in 500 ll of DMEM (10 % FCS, 1 %
P&S) and incubated at 37 C, in 5 % CO2 for 24 h to
facilitate cell attachment. The 0.4 mg ml-1 micelle solu-
tions were filter sterilised (0.22 lm) before preparing a
series of 10-fold serial dilutions in DMEM (2.5 % FCS,
1 % P&S) to provide polymer concentrations of 200, 20, 2,
0.2 and 0.02 lg ml-1. After the 24 h cell attachment pe-
riod, the supplemented DMEM was removed from the cells
and replaced with 500 ll of the prepared dilutions of the
polymer solutions, pre-warmed to 37 C (four replicate
wells per test concentration). Control samples of PBS and
MeOH at the concentrations used for the polymer samples
were also prepared and tested. A blank control plate con-
taining cells in fresh DMEM supplemented with 2.5 %
FCS and 1 % P&S was used to provide the 100 % survival
figure. The plates were incubated at 37 C in 5 % CO2 for
5 days to allow cell colonies to grow. The FCS concen-
tration was reduced to 2.5 % from 10 % to attenuate cell
growth. After 5 days the resultant colonies were fixed with
gluteraldehyde (Sigma, UK) and stained with 10 % v/v
Giemsa stain (Sigma, UK). The numbers of colonies in
each well were counted and the percentage of colony re-
duction compared to the control wells was calculated for
each dilution of each sample type.
2.4.2 Cellular uptake of dye loaded micelles
V79 cells were maintained in DMEM supplemented with
10 % FCS and 1 % P&S, and seeded into 24 well plates at
1,000 cells per well in 500 ll of DMEM (2.5 % FCS, 1 %
P&S) and incubated at 37 C, in 5 % CO2 for 48 h.
MPC100–DPA100 (MeOH–PBS) micelle systems loaded
with NR (10:0.5 w/w ratio) were prepared as per
Sect. 2.2.4, substituting the PBS with DMEM (2.5 % FCS,
1 % P&S) in order to produce a final polymer
concentration of 200 lg ml-1. The prepared polymer mi-
celle solution, with NR, in DMEM (2.5 % FCS, 1 % P&S)
was filter sterilised (0.22 lm), and used to replace the
DMEM on the incubated cells. The cells were then incu-
bated for a further 48 h at 37 C, in 5 % CO2. At the 96 h
time point, fresh DMEM was used to replace the test
samples in the wells, having washed the wells twice with
1 ml sterile PBS beforehand. The cells were then observed
using a Leica SP5 confocal laser scanning microscopy
(CLSM) equipped with an argon laser, using an excitation
wavelength of 514 nm, and an emission collection wave-
length band of 550–617 nm.
3 Results
3.1 Solvent ratio, time, and dialysis effect
A range of MeOH and EtOH solvent v/v ratio combina-
tions were used to prepare micelle systems of MPC100–
DPA100 in PBS. The PCS data (Dh and Pd) presented in
Fig. 1 indicated that for systems prepared from 100 %
MeOH, and MeOH:EtOH ratios of 3:1, and 1:1 the mean
Dh was circa 70 nm. When the EtOH ratio was increased to
3:1 the Dh increased to a mean of circa 82 nm, and the
100 % EtOH system increased the mean Dh to circa
128 nm. The Pd of the 100 % MeOH derived system was
below 0.1, indicating a monodisperse population, however
as the EtOH ratio increased so did the Pd of the systems,
going beyond 0.2 in some cases, indicating the develop-
ment of polydisperse broader particle size range systems.
Comparison of the t = 0 with 6 data presented in Fig. 1
indicated that the systems were stable over a 6 week
storage period, with the Dh and Pd of the systems re-
maining relatively consistent for that period. The pre and
Fig. 1 Particle diameter (outer bar) and polydispersity (inner bar),
measured with PCS (25 C), of MPC100–DPA100 micelles, formed via
nanoprecipitation from solvent (MeOH, EtOH, and v/v combinations
of), in PBS (pH 7.4), at time zero (t = 0) and 6 weeks post formation
(t = 6) (Mean ± SD, n = 6)
150 Page 4 of 14 J Mater Sci: Mater Med (2015) 26:150
123
post dialysis data displayed in Fig. 2 agreed with the data
in Fig. 1, and indicated that dialysis of the systems had
little discernable effect on their average Dh and Pd.
3.2 Solvent, buffer, hydrophobic loading, dilution,
and temperature effect
MPC100–DPA100 micelle systems were prepared in either
McB (pH 7.4) or PBS (pH 7.4) via nanoprecipitation using
EtOH and MeOH, with and without OOT, as displayed in
Fig. 3. The systems prepared using EtOH, both with and
without OOT, and in PBS and McB, produced micelle
systems with a mean Dh of circa 128 nm, and high Pd
values exceeding 0.2, indicating the presence of polydis-
perse systems. The MeOH prepared systems, both with and
without OOT, in PBS and McB produced micelle systems
with mean Dh values of circa 70 and 74 nm, respectively,
with low, monodisperse, Pd values below 0.1 for both
systems. Thus the data in Fig. 3 indicated that the choice of
buffer or loading with a hydrophobic compound (OOT) did
not significantly alter the mean Dh and Pd of the either the
EtOH or MeOH prepared systems, with only minor Dh
changes observed when the buffer was switched for the
MeOH systems.
The PBS based systems were further investigated, as
displayed in Fig. 4(a–d) examining dilution stability of the
micelles, with regard to the Dh and PCS signal intensity.
The EtOH–PBS systems, without (a) and with (b) OOT
loaded demonstrated good resistance to micelle disso-
ciation as the polymer concentration was halved with each
dilution point, resulting in a steady decrease in signal in-
tensity. The MeOH–PBS systems, without (c) and with
(d) OOT loaded also displayed resistance to dilution in-
duced micelle dissociation, as was evident by measureable
particles down to the limit of detection for the PCS in-
strument, circa 5 KCps.
For the EtOH–PBS systems, particles were detectable
down to a concentration of 0.0125 lM (Fig. 4a, b), with an
accompanying gradual reduction in the KCps signal in-
tensity indicating that there were no sharp changes in mean
particle size, which would have been seen upon a micelle
to unimer shift, thus suggesting the persistent presence of
micelles. The MeOH–PBS based systems were measurable
down to 0.0625 lM, and also displayed a gradual reduction
on signal intensity associated with particle stability.
The systems were assessed for their temperature sta-
bility, with regard to Dh, across the temperature range of
5–70 C, as shown in Fig. 5. The EtOH–PBS systems, with
and without OOT, remained stable throughout the tem-
perature, with only a minor reduction in Dh at the highest
temperature of 70 C, with average Dh otherwise remain-
ing circa 128 nm for the systems. The MeOH–PBS system,
with and without OOT, also remained stable over the tested
temperature range, with average Dh of circa 70 nm.
3.3 Atomic force microscopy (AFM)
and Transmission electron microscopy (TEM)
AFM and TEM imaging was undertaken to further explore
the size and morphology of the MPC100–DPA100 MeOH
system. AFM imaging revealed a uniform population of
nanoparticles with a spherical morphology, seen as light
particles against a darker background in Fig. 6. TEM
imaging also indicated the presence of spherical particles,
seen as light against the dark background in Fig. 7. The
particle size indicated by AFM and TEM was circa
50–80 nm.
Fig. 2 Particle diameter (outer bar) and polydispersity (inner bar),
measured with PCS (25 C), of MPC100–DPA100 micelles, formed via
nanoprecipitation from solvent (MeOH, EtOH, and v/v combinations
of), in PBS (pH 7.4), pre and post dialysis (Mean ± SD, n = 6)
Fig. 3 Particle diameter (outer bar) and polydispersity (inner bar),
measured with PCS (25 C), of MPC100–DPA100 micelles, formed via
nanoprecipitation from solvent (MeOH or EtOH), in McB (pH 7.4)
and PBS (pH 7.4), with and without OOT entrapped (Mean ± SD,
n = 6)
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3.4 Stirring, sonication, and filtration effect
To further optimise the preparation process the effects of
stirring, sonication, and filtration upon Dh and Pd of the
MeOH–PBS based system was examined. The results dis-
played in Fig. 8 show that the control samples (A), pre-
pared using no stirring, sonication, or filtration during or
after nanoprecipitation resulted in systems with average a
Dh of circa 113 nm, and high mean Pd value of circa 0.6,
suggesting the presence of a polydisperse system with
larger, less well ordered, particle sizes. However, the
samples prepared using filtration alone (B), stirring and
sonication with no filtration (C), and stirring, sonication,
and filtration combined (D), all resulted in systems with
average Dh values circa 70 nm and low Pd values. The
results indicated that it was only necessary to filter
Fig. 4 Particle diameter and signal intensity (KCps), in response to
dilution, of MPC100–DPA100 micelles measured with PCS (25 C),
formed via nanoprecipitation from solvent into buffer. a Ethanol–
PBS, b ethanol–PBS–OOT, c methanol–PBS, d methanol–PBS–OOT
(Mean ± SD, n = 6)
Fig. 5 Particle diameter in response to temperature measured with
PCS (5–70 C), of MPC100–DPA100 micelles, formed via nanopre-
cipitation from solvent (MeOH or EtOH), in PBS (pH 7.4), with and
without OOT entrapped (Mean ± SD, n = 6)
Fig. 6 AFM Tapping ModeTM image of MPC100–DPA100 nanopar-
ticle micelles displaying diameters in the order of 60–70 nm
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(0.22 lm) the system after nanoprecipitation in order to
reproducibly produce monodisperse systems (Pd below
0.1), thus removing the requirement for the previous stir-
ring and sonication steps.
3.5 Loading ratio of fluorescent probe
In order to assess cellular uptake of the MPC100–DPA100
MeOH–PBS system, the fluorescent dye Nile Red (NR)
was loaded into the system. Figure 9 illustrates the effect
that alterations in the polymer:dye ratio had on the Dh and
Pd of the system. It can be seen that at the w/w ratios of
10:0.1, 10:0.5, and 10:0.75 the system remained stable,
with a Dh of circa 70 nm and Pd below 0.1, indicating
monodispersity. At the ratio of 10:1 the Dh increased
markedly to circa 167 nm, with a Pd of circa 0.4, sug-
gesting the presence of a polydisperse system with larger,
less well ordered, particle sizes.
3.6 Cytotoxicity and cellular uptake
The in vitro cytotoxicity of the MPC100–DPA100 micelles
was investigated by comparing the cell colony formation
numbers of the polymer micelle containing samples, with
those of a polymer-free cell medium control plate. The data
indicated that the micelles were essentially non-toxic at the
tested concentrations, as seen in Fig. 10, and that the PBS
and methanol controls also displayed similarly low levels
of cellular toxicity at all but the highest concentration
tested.
Fig. 7 TEM image of MPC100–DPA100 nanoparticle micelles dis-
playing micelle diameters in the order of 50–80 nm
Fig. 8 Particle diameter (outer bar) and polydispersity (inner bar),
measured with PCS (25 C), of MPC100–DPA100 micelles, formed via
nanoprecipitation from MeOH in PBS (pH 7.4), illustrating the effect
of filtration, stirring, and sonication on the Dh and Pd (Mean ± SD,
n = 6)
Fig. 9 Particle diameter (outer bar) and polydispersity (inner bar),
measured with PCS (25 C), of MPC100–DPA100 micelles, loaded
with Nile Red, formed via nanoprecipitation from MeOH in PBS (pH
7.4), illustrating the effect of alterations to the polymer:dye w/w
loading ratio upon the Dh and Pd (Mean ± SD, n = 6)
Fig. 10 The in vitro cytotoxicity of the MPC100–DPA100 micelles
(MeOH–PBS system) tested on V79 cells. The percent survival of test
sample cells was derived from comparison to cell medium only
control wells. Samples were incubated for 5 days at 37 C in 5 %
CO2 (Mean ± SD, n = 6)
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The cellular uptake of MPC100–DPA100 (MeOH–PBS)
micelles loaded with NR florescent dye was investigated
using CLSM and V79 cells. A seen in Fig. 11 an apparent
uptake of the NR loaded micelles was observed, as evi-
denced by the NR fluorescence (a), whilst the brightfield
image (b) of the same field of view indicated that the cells
had maintained a healthy morphology.
4 Discussion
Previous work has demonstrated that MPC–DPA copoly-
mers molecularly dissolve in acidic solutions, form mi-
celles when deprotonated in higher pH solutions, will
dissociate when the pH is lowered again, and in doing so
can be used to controllably load, deliver, and release hy-
drophobic compounds in vitro, whilst maintaining colloidal
stability at physiological pH [17, 24]. Upon cellular inter-
nalisation, via endocytosis [25], the micelles are exposed to
a low pH environment [26] which brings about micelle
dissociation and drug release. It is therefore hypothesised
that MPC–DPA micelles could be further developed and
optimised to provide efficacious systemic delivery of
clinically relevant therapeutic compounds, for example
anticancer drugs, with recent in vivo studies continuing to
support this concept [22]. The MPC component of the
copolymer offers biomimetic and non-thrombogenic
properties [15, 27, 28] which may provide the micelle
corona with biocompatible performance in a similar man-
ner to poly (ethylene glycol) (PEG) shielded Stealth lipo-
somes [29], and thus in principle afford the MPC–DPA
micelles a level of protection and defence against op-
sonisation induced RES clearance. Therefore the accurate
and reproducible control of particle size, and polydisper-
sity, is fundamental to effective biodistribution, and thus
central to engineering long circulating MPC–DPA based
NIDS, as particle size acutely influences RES clearance
[1], particle accumulation at tumour sites via EPR [13, 14],
and the rate and route of cellular internalisation via endo-
cytosis [30]. Indeed, the poorly water soluble anti-cancer
drugs tamoxifen and paclitaxel have been successfully
loaded into other MPC–DPA based micelles [21, 24].
The principles of the nanoprecipitation method of mi-
celle formation, also referred to as solvent displacement or
solvent injection, have previously been employed to pre-
pare a range of alternative nanoparticle systems [31–35]
and was herein optimised for the polymer MPC100–
DPA100. In this study nanoprecipitation proved to be an
effective, rapid and straight forward micellisation tech-
nique, producing monodisperse micelle systems with mean
diameters of circa 70 nm when using MeOH as the solvent
and PBS as the non-solvent. This was a significant im-
provement over the previously employed pH titration
method of MPC–DPA micelle formation which had pro-
duced smaller micelles with a higher level of polydispersity
[17]. Interestingly, EtOH-based systems produced larger
particles than the MeOH derived systems (Fig. 1), an effect
which has also been reported for other nanoprecipitation
based polymeric micelle systems exploring solvent selec-
tion [34, 35] and attributed to differing solubility of the
polymers between solvents. PC based polymers have been
reported to be soluble across the full range of
methanol:water ratio mixes, whilst being less soluble in
ethanol:water mixes, credited to the affinity of the PC
headgroup to the alcohols relative to the water content, and
the resultant co-nonsolvency effects [36, 37], which may
Fig. 11 Confocal laser scanning microscopy image of V79 cells
incubated with NR loaded MPC100–DPA100 micelles (MeOH–PBS
system). Image a displays NR fluorescence, indicating apparent
uptake of the NR loaded micelles, whilst image b provides brightfield
evidence of healthy cell morphology
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account for the contrasting results observed in this work.
Moreover, these findings were in good agreement with
other work, that found the choice of solvent could influence
particle size, and blends of solvents could be used to
control particle size [34, 35, 38].
The maximum theoretical length of an MPC100–DPA100
unimer is 60 nm fully extended, based on a 0.15 nm carbon
to carbon length, with each residue joined at a carbon bond
and with one carbon (0.15 nm) between residues. However
taking into account the 120 carbon bond angle, the dis-
tance between each residue of the polymer would be
0.26 nm, and therefore the unimer length would be 52 nm.
In micelle form if the aggregated unimers were unfolded
and had no hydrophobic domain overlap, the maximum
theoretical micelle diameter would be 104 nm, herein the
PCS measurements indicated the MeOH based particles
were circa 70 nm, and EtOH system particles were circa
128 nm in diameter. Therefore whilst the MeOH system
particles fit the size profile for micelles, the EtOH systems
exceeded the maximum theoretical micelle diameter, and
would thus appear to be more complex structures, possibly
wormlike micelles or vesicles, further TEM imaging would
help resolve this. Additionally any residual EtOH and
MeOH in the buffer, post-injection, may have affected the
solubility of the polymer, and thus lead to the difference in
particle size observed, however the subsequent exhaustive
dialysis (Fig. 2), utilised to remove residual solvent, indi-
cated this was unlikely to be the case, as particle size re-
mained unchanged post-dialysis. However, it is clear that
choice of solvent can affect the size, and possibly mor-
phology of the MPC–DPA particles, as reported for other
systems [34, 35, 38, 39].
The EtOH and MeOH based systems were reproducible
in both PBS and McB (Fig. 3), with only a slight reduction
in particle diameter for MeOH in PBS versus the McB, but
solution ionic strength is reported to influence micelle ag-
gregation number, critical micelle concentration (CMC),
and size [40, 41], however loading of the hydrophobic
model compound OOT did not produce any discernable
changes to the systems. Loading micelles with hydrophobic
compounds can result in particle size changes [42–44] as
has been seen in other MPC–DPA based micelle systems
[24], however the previous micelle preparation method
differed from that used for this study, which may account
for apparent variance in particle size and stability. In
contrast the MPC100–DPA100 systems were principally
stable for both hydrophobic model compounds loaded,
(Figs. 3, 9), until a 10:1 (w/w) polymer:dye ratio was
reached (Fig. 9).
Polymeric micelle systems often possess very low CMC
values and display good resistance to dissociation [2, 3].
The results of this study indicated that the MPC100–DPA100
micelles were highly resistant to dilution induced micelle
dissociation, which is a major challenge for systemically
administered self-assembling NIDS to overcome. The
MPC100–DPA100 micelles were detectable, using PCS,
down to polymer concentrations of 3.125 and 0.625 mg l-1
for MeOH and EtOH respectively in PBS, which were 10-
and 100-fold improvements over the previous pH titration
system CMC for the polymer [17]. The dilution stability
values determined (Fig. 4) were also comparable to CMC
values published for other MPC–DPA micelle systems,
ranging from 4 to 25 mg l-1 [45, 46] as well as other
copolymers containing either MPC or DPA ranging from
3.1 to 43 mg l-1 [47, 48]. Indeed it is possible that the
micelle systems employed in this study would persist at
lower polymer concentrations, as polymeric micelles have
been found to have very low CMC values combined with
high particle stability and slow particle dissociation [2, 3];
however the limit of detection for the PCS measurement
was reached. Further study utilising pyrene solubilisation
[36] would help elucidate this.
Temperature and time stability of candidate NIDS is of
great importance if they are to be medically developed, as
both thermal robustness and long term colloidal stability
will influence the storage and handling requirements of the
systems, and thus their ease of use in a full range of clinical
settings. The MPC100–DPA100 micelle systems displayed
good thermal stability, with no critical micelle temperature
(CMT) or cloud points observed across a wide temperature
range (Fig. 5), which was in contrast to other MPC–DPA
micelle systems [49] which were reported to vary in par-
ticle diameter as temperature changed, possibly due to
thermally induced micelle phase transitions [50], but again
the micelle preparation method differed from that used for
this study, as did the MPC–DPA block lengths, which may
account for this variance. The thermal stability (Fig. 5),
together with the stability over time observed (Fig. 1)
indicate the MPC100–DPA100 systems have the potential to
be adaptable to a range of storage and transport options.
In this current study the particle size for the MeOH
based system indicated from the AFM imaging (Fig. 6)
was in close agreement with the mean diameter (circa
70 nm) measured using PCS (Fig. 3), as was the TEM
imaging result (Fig. 7). These TEM results were similar to
reported diameters determined by TEM for other MPC–
DPA micelles [24, 45, 46] but noting these systems were of
different MPC–DPA block length ratios, and not prepared
by using the nanoprecipitation method developed in this
study. The negative staining technique used for the TEM
imaging was an established method [3, 51, 52] and the
resultant TEM image (Fig. 7) was comparable to other
published negatively stained micelle TEM images, likewise
the AFM image (Fig. 6) was also similar to other micelle
system AFM images [53]. With regard to the wider particle
diameter size range observed by TEM and AFM, compared
J Mater Sci: Mater Med (2015) 26:150 Page 9 of 14 150
123
to PCS, the micelles were fully hydrated and in an aqueous
solution for PCS analysis, however during AFM and TEM
sample preparation it is not unusual for micelles to spread,
flatten, shrink, or contract during staining and drying, as
they are not solid particles.
In order to optimise nanoprecipitation for the MPC–
DPA micelles prepared from MeOH–PBS, the effect of
stirring, sonication, and filtration upon the micelle solu-
tions was examined (Fig. 8), all of which are commonly
used methods published for micelle formation, and more so
in the formation of polymersomes [20, 54, 55]. It was
found in this case that there was no benefit observed from
the stirring or sonication of the MPC100–DPA100 micelles,
indeed it was found that sonication increased the polydis-
persity of the systems, possibly due to disruption of the
micelles into a wider average diameter range, and that
filtration was the only post-precipitation step required to
achieve good monodispersity. The filtration step may have
been acting as an extrusion process to induce the observed
uniformity in the systems, as extrusion is one of a number
of steps required to obtain uniform MPC–DPA and other
polymersomes [54, 55]. In terms of further development, it
has been reported that increasing the volume of solvent
used for nanoprecipitation will increase the number or
concentration of micelles in the solution, whilst increasing
the polymer concentration will increase particle size [34,
35], which together with the solvent effects observed in this
study, provides a large scope for further investigation.
The results from the in vitro cytotoxity assay (Fig. 10)
indicated that the MPC100–DPA100 polymer was of very
low cellular toxicity, which was in good agreement with
other MPC–DPA polymers tested [17, 21, 56]. The small
reduction in cell survival observed at 200 lg ml-1 polymer
concentration was possibly due to the 50 % dilution of cell
medium at the initial dilution step causing cell stress or
reduced cell growth, rather than presence of the polymer,
as the PBS control also displayed similar results. Similarly
the MeOH used in sample preparation, and control volumes
tested, also did not present any evidence of cellular toxicity
over the PBS control. The V79 fibroblast cells may inter-
nalise nanoparticles via endocytosis [30], and an apparent
uptake of the MPC100–DPA100 micelles was observed here
using CLSM (Fig. 11a), with brightfield data (Fig. 11b)
also displaying healthy cell morphology after exposure to
the polymer, as further evidence of low cellular toxicity.
Indeed a wide range of cell types have been exposed to
MPC25–DPA70 polymersomes [54], none of which dis-
played any significant signs of toxicity, and thus the
MPC100–DPA100 micelles should also be biocompatible.
Whilst the existing MPC–DPA polymersome systems have
a number of benefits, most notably the ability to deliver
both hydrophobic and hydrophilic compounds [19, 20, 54,
56], the sample preparation required to attain the desired
particle size and polydispersity is complex, whilst in con-
trast, these MPC100–DPA100 micelles offer the prospect of
easily prepared reproducible monodisperse micelle sys-
tems, with the potential to deliver a wide range of poorly
water soluble compounds.
Despite the small volume of MeOH used during the
nanoprecipitation process, the potential toxicity of MeOH
[57] cannot be ignored, and as such MeOH is often ex-
cluded from studies due to its inherent Class 3 toxicity
rating [34]. However the results of this study are very
promising in terms of controllable micelle system charac-
teristics and properties, and this positive data warrants
further investigation into methods to achieve and confirm
removal of the MeOH. Moreover, given the cell assay data
(Fig. 10) indicated that there was no residual toxicity from
the MeOH used to prepare the micelles, it may be the case
that MeOH dissipates from the system at ambient tem-
perature. Additionally, given the boiling point of MeOH is
approximately 65 C, there was no evidence of micelle
system shifts or alterations at 70 C during PCS tem-
perature scans (Fig. 5). The toxicity of the MeOH should
also be taken into context of the application and the desired
effect, for instance in the case of anti-cancer drug delivery,
agents such as paclitaxel and doxorubicin are inherently
toxic themselves, thus further investigation into under-
standing MeOH tolerance levels could be warranted, given
low levels of unaccounted MeOH exposure occurs via
environmental and dietary exposure. Indeed many phar-
maceutical and medicinal compounds have serious side
effects and wider health implications, but the benefit of
treatment is perceived to outweigh these.
The MPC100–DPA100 diblock copolymer investigated in
this study is essentially surfactant like, in that it is com-
prised of hydrophobic and hydrophilic domains, and in
theory at a concentration above the CMC the unimeric
polymer chains would to aggregate together to form mi-
celles, with the hydrophobic blocks forming the core of the
micelles [58]. The micellisation process is an example of
the hydrophobic effect [59], where non-polar molecules or
non-polar parts of molecules are spontaneously removed
from water [60]. The primary driving force of this being
the large energy required to form a cavity in the water to
accommodate the hydrophobe, which is thermody-
namically unfavourable and thus decreases the solubility of
the hydrophobic molecules and favours micellisation [61].
The large energy is required because of the high cohesion
of water molecules resulting from the high hydrogen
bonding density [60]. The hydrophobic effect thus provides
the driving force for the aggregation of the hydrophobic
polymer domains, whilst electrostatic repulsion between
the polar, water soluble, hydrophilic domains or head
groups can control the shape and size the micelles [62].
Thus, in reality the shape of micelle based systems is
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controlled by the balance between these attractive hy-
drophobic and repulsive electrostatic forces [63]. The hy-
drophobic force will try to minimise the surface area to
avoid water contact, whilst the repulsive force will try to
maximise the surface area to keep the polar domains as far
apart as possible [64]. This can ultimately lead to the
spontaneous curvature of micelle formation, as the curva-
ture allows a greater spacing between the polar domains
than a planar bilayer [65]. In terms of drug loading, when a
drug is mixed with micelles or surfactant molecules they
may interact as a result of the hydrophobic effect and also
electrostatic effects [66]. Drugs with no significant hy-
drophobic surface area may interact with the micelles or
surfactants as a result of electrostatic effects arising from
the charge associated with the drug and surfactant mole-
cules. For drugs or hydrophobic compounds with a large
hydrophobic surface area the hydrophobic effect will drive
their interaction [66], although other chemical interactions
may also occur, such a dipole interactions and hydrogen
bonding depending on the chemical structure of the drug or
surfactant [67]. The result of this hydrophobic effect is that
poorly water soluble hydrophobic compounds, for example
OOT and NR, will preferentially partition into the hy-
drophobic domain of the micelle core and undergo hy-
drophobic interactions [68].
Whilst the NR fluorescent probe employed in this study
was hydrophobic, negligibly water soluble, and thus should
preferentially partition into the core [68] of the MPC100–
DPA100 micelles due to the hydrophobic effect [59–61],
there is evidence from other MPC–DPA based micelle
systems loaded with hydrophobic compounds, that a slow
diffusion based release of the hydrophobic load at pH 7.4
can occur [24, 45]. However it should be noted that the
studies [24, 45] were based on an excess volume dialysis
model, rather than a fixed small volume and concentration
system reflective of a tissue culture well. Given that mi-
celles are generally considered to be thermodynamically
stable above their CMC [45, 58], and noting that the
polymer concentration utilised for the CLSM assay was
200 lg ml-1, with Fig. 4 indicating micelle stability at that
concentration, it suggests that the MPC100–DPA100 mi-
celles would persist at the concentration tested. Addition-
ally, as the presence of hydrophobic compounds can
enhance micelle stability [44], and the time data from this
current study (Fig. 1) further suggested excellent colloidal
stability, any micelle dissociation and NR release should
therefore be minimal during the CLSM in vitro cell uptake
assay.
However, the possibility remains that NR may have
slowly diffused from the micelles during the assay incu-
bation period, resulting in the cellular staining observed
(Fig. 11). But, given the apparently rapid uptake of other
MPC–DPA based systems [56], some of the NR loaded
micelles may have undergone endocytosis into the cells
and contributed to the fluorescence observed. As such,
further study of the system with higher resolution mi-
croscopy would help elucidate this, as NR released in so-
lution would be expected to primarily stain the lipid
containing outer cell membrane, whereas micelle loaded
NR should undergo cellular internalisation via endocytosis
[21, 30, 56], and potentially enhance the level of fluores-
cent staining achieved [54]. Moreover, this could be further
explored by preparing fluorescent dye labelled MPC–DPA
[20], which would facilitate the investigation of both the
fate of the micelle upon internalisation, and an additional
second fluorescent dye loaded into micelle, and thus
identify any co-localisation of the micelle and loaded dye.
Whilst the MeOH derived systems investigated here
appeared to form surfactant-like spherical micelle struc-
tures, the larger particle diameter of the EtOH based sys-
tems suggests they may have formed more complex
structures. It has been suggested for MPC–DPA polymers
that when the DPA block length reaches approximately
twice that of MPC block, then vesicle like polymersomes
will form rather than micelles [49], indeed 140 nm di-
ameter MPC25–DPA120 based vesicle-like particles have
been reported [19] and a range of other polymersomes sizes
greater than 100 nm diameter have been reported for
MPC25–DPA70 [20, 54, 56] however in this instance, given
the equal block length MPC100–DPA100 polymer, it would
therefore be expected that micelles would be the pre-
dominate structure assembled.
The transition from spherical micelles to vesicles or
polymersomes involves intermediate structures in the form
of cylindrical or wormlike micelles [69] with solvent se-
lectivity, block length and ratio [70], temperature, and the
presence of salts and additives bringing about the transition
of AB diblock copolymers from spherical micelles to a
cylindrical or wormlike morphology [71, 72]. It is possible
for rod or cylinder-like morphologies to further aggregate
and form curved, bowl-shaped structures which can close
over to form vesicles [73]. Therefore, given that the MPC–
DPA polymer used for this study were also AB diblock
copolymers it is possible that they may also have under-
gone transformation from spherical micelles to a cylinder
or wormlike morphology and possibly through to vesicle
formation, which may therefore account for the larger
particle size seen for the EtOH based systems.
The principle concept for these MPC–DPA micelle
systems, is that they are dynamic and controllable, and
given the correct polymer, system conditions, and prepa-
ration parameters, have the potential to form a large
number of organised structures [49] including spherical
micelles, wormlike cylindrical micelles, and vesicles, all of
which presents substantial scope for further investigation
and research.
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5 Conclusions
In conclusion, progressing from work published previously
on MPC–DPA micelles [17, 24] these results suggest that
the MPC–DPA diblock copolymers continue to offer the
potential for the development of long circulating stimuli
responsive micelle NIDS. The reproducible monodisperse
nature of the MPC100–DPA100 micelles, together with the
demonstrated thermal and dilution stability, lends itself to
the possibility that further designer micelles could be
engineered to very specific diameters by alteration of the
MPC and DPA block lengths. Indeed it has been suggested
that the ratio between MPC and DPA is critical for the size
and morphology of the particles formed [49], and as such
developing accurate control of particle size and polydis-
persity is inherent to optimising control of NIDS bio-
distribution.
This paper has described for the first time the development
and optimisation of a novel preparation process, utilising
nanoprecipitation, for monodisperse MPC–DPA micelle
nanoparticle systems. These nanoparticles possess key
biomimetic and pH responsive properties [17, 24] required for
development of in vivo applications. OOT and NR were
employed as model therapeutic compounds to test the sys-
tems, resulting in the successful formation of stable
monodisperse micelles, with an apparent in vitro cellular de-
livery of these being demonstrated. These encouraging results
highlight the continued potential for MPC–DPA systems to be
utilised for a variety of intracellular delivery applications, for
example anticancer, antimicrobial, and diagnostic imaging,
harnessing the hydrophobic nature of many therapeutics to
overcome their intrinsically low water solubility.
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